Serum low-molecular-weight protein fractionation for biomarker discovery

7Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Protein biomarkers provide the key diagnostic information for the detection of disease, risk of disease progression, and a patient's likely response to drug therapy. Potential biomarkers exist in biofluids, such as serum, urine, and cerebrospinal fluid. Unfortunately, discovering and validating protein biomarkers are hindered by the presence of high-molecular-weight proteins, such as serum albumin and immunoglobulins, which comprise 90% of the proteins present in these samples. High-abundance, high-molecular-weight proteins mask the low-molecular-weight (LMW) proteins and peptides using conventional protein detection methods. Candidate biomarkers are believed to exist in very low concentrations and comprise less than 1% of serum proteins, and may be highly labile as well. Therefore, it is imperative to isolate and enrich LMW proteins from complex mixtures for biomarker discovery. This chapter describes a continuous -elution electrophoresis method, based on molecular weight sieving, to isolate specific molecular weight fractions for mass spectrometric, western blotting, or protein array analysis. © 2012 Springer Science+Business Media, LLC.

Cite

CITATION STYLE

APA

Vanmeter, A. J., Camerini, S., Polci, M. L., Tessitore, A., Trivedi, N., Heiby, M., … Zhou, W. (2012). Serum low-molecular-weight protein fractionation for biomarker discovery. Methods in Molecular Biology, 823, 237–249. https://doi.org/10.1007/978-1-60327-216-2_15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free